164 related articles for article (PubMed ID: 10066664)
1. Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis.
Wolter JM; Rodwell RL; Bowler SD; McCormack JG
Clin Diagn Lab Immunol; 1999 Mar; 6(2):260-5. PubMed ID: 10066664
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa.
Jones AM; Martin L; Bright-Thomas RJ; Dodd ME; McDowell A; Moffitt KL; Elborn JS; Webb AK
Eur Respir J; 2003 Sep; 22(3):503-6. PubMed ID: 14516142
[TBL] [Abstract][Full Text] [Related]
3. Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6.
Majka G; Mazurek H; Strus M; Ciszek-Lenda M; Szatanek R; Pac A; Golińska E; Marcinkiewicz J
Clin Exp Immunol; 2021 Sep; 205(3):391-405. PubMed ID: 34031873
[TBL] [Abstract][Full Text] [Related]
4. Cytokines in neutrophil-dominated airway inflammation in patients with cystic fibrosis.
Schuster A; Haarmann A; Wahn V
Eur Arch Otorhinolaryngol; 1995; 252 Suppl 1():S59-60. PubMed ID: 7537567
[TBL] [Abstract][Full Text] [Related]
5. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study.
Ordoñez CL; Stulbarg M; Grundland H; Liu JT; Boushey HA
Pediatr Pulmonol; 2001 Jul; 32(1):29-37. PubMed ID: 11416873
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory and immunological biomarkers are not related to survival in adults with Cystic Fibrosis.
Moffitt KL; Martin SL; Jones AM; Webb AK; Cardwell C; Tunney MM; Elborn JS
J Cyst Fibros; 2014 Jan; 13(1):63-8. PubMed ID: 23860440
[TBL] [Abstract][Full Text] [Related]
7. TNF-alpha and IL-8 in consecutive sputum samples from cystic fibrosis patients during antibiotic treatment.
Karpati F; Hjelte FL; Wretlind B
Scand J Infect Dis; 2000; 32(1):75-9. PubMed ID: 10716082
[TBL] [Abstract][Full Text] [Related]
8. Cytokine concentrations and neutrophil elastase activity in bronchoalveolar lavage and induced sputum from patients with cystic fibrosis, mild asthma and healthy volunteers.
McGarvey LP; Dunbar K; Martin SL; Brown V; Macmahon J; Ennis M; Elborn JS
J Cyst Fibros; 2002 Dec; 1(4):269-75. PubMed ID: 15463826
[TBL] [Abstract][Full Text] [Related]
9. Plasma interleukin-1 alpha and beta, tumor necrosis factor-alpha, and lipopolysaccharide concentrations during pulmonary exacerbations of cystic fibrosis.
Wilmott RW; Frenzke M; Kociela V; Peng L
Pediatr Pulmonol; 1994 Jul; 18(1):21-7. PubMed ID: 7970903
[TBL] [Abstract][Full Text] [Related]
10. [Immunologic monitoring of patients with cystic fibrosis: value of different laboratory findings].
Pevnitskiĭ LA; Pukhal'skiĭ AL; Kapranov NI; Kalashnikova EA; Shmarina GV; Pukhal'skaia DA; Kokarovtseva SN; Kashirskaia NIu; Shabalova LA
Vestn Ross Akad Med Nauk; 2000; (5):40-6. PubMed ID: 10881662
[TBL] [Abstract][Full Text] [Related]
11. Circulating immunoreactive interleukin-6 in cystic fibrosis.
Nixon LS; Yung B; Bell SC; Elborn JS; Shale DJ
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1764-9. PubMed ID: 9620903
[TBL] [Abstract][Full Text] [Related]
12. Airway inflammation and etiology of acute exacerbations of chronic bronchitis.
Sethi S; Muscarella K; Evans N; Klingman KL; Grant BJ; Murphy TF
Chest; 2000 Dec; 118(6):1557-65. PubMed ID: 11115440
[TBL] [Abstract][Full Text] [Related]
13. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy.
Colombo C; Costantini D; Rocchi A; Cariani L; Garlaschi ML; Tirelli S; Calori G; Copreni E; Conese M
Pediatr Pulmonol; 2005 Jul; 40(1):15-21. PubMed ID: 15858808
[TBL] [Abstract][Full Text] [Related]
14. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients.
Hansen CR; Pressler T; Nielsen KG; Jensen PØ; Bjarnsholt T; Høiby N
J Cyst Fibros; 2010 Jan; 9(1):51-8. PubMed ID: 19939747
[TBL] [Abstract][Full Text] [Related]
15. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection.
Pukhalsky AL; Kapranov NI; Kalashnikova EA; Shmarina GV; Shabalova LA; Kokarovtseva SN; Pukhalskaya DA; Kashirskaja NJ; Simonova OI
Mediators Inflamm; 1999; 8(3):159-67. PubMed ID: 10704054
[TBL] [Abstract][Full Text] [Related]
17. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha(1)-antitrypsin deficiency (PiZ).
Hill AT; Campbell EJ; Bayley DL; Hill SL; Stockley RA
Am J Respir Crit Care Med; 1999 Dec; 160(6):1968-75. PubMed ID: 10588615
[TBL] [Abstract][Full Text] [Related]
18. Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
Cantin AM; Berthiaume Y; Cloutier D; Martel M
Clin Invest Med; 2006 Aug; 29(4):201-7. PubMed ID: 16986483
[TBL] [Abstract][Full Text] [Related]
19. Host inflammatory responses to first isolation of Pseudomonas aeruginosa from sputum in cystic fibrosis.
Elborn JS; Cordon SM; Shale DJ
Pediatr Pulmonol; 1993 May; 15(5):287-91. PubMed ID: 8327287
[TBL] [Abstract][Full Text] [Related]
20. Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multi-parametric biochip array in cystic fibrosis.
Colombo C; Faelli N; Tirelli AS; Fortunato F; Biffi A; Claut L; Cariani L; Daccò V; Prato R; Conese M
Int J Immunopathol Pharmacol; 2011; 24(2):423-32. PubMed ID: 21658316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
